Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

Canaccord Genuity began coverage on Orthofix International (NASDAQ:OFIX), assigning a Buy rating and setting a price target of $24.00. The firm's analysis suggests that Orthofix, following its merger ...

DelveInsight Analysis: The Orthopedic Trauma Devices market size is expected to grow at a CAGR of 6.43% during the forecast period (201-26) to reach USD 10.08 billion by 2030. Which MedTech key ...

Shares of Versus Systems Inc. VS +76.6% + Free Alerts rose sharply in today's pre-market trading after the company announced ...

Corporate crises happen—and that means we have to plan for them. While it isn’t practical to prepare for every possible corporate crisis, there ...

CHARLOTTESVILLE, Va., Jan. 14, 2025 /PRNewswire/ -- MicroAire Surgical Instruments, a Marmon Holdings | Berkshire Hathaway company focused on plastic and upper extremity surgery, is pleased to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...